Small Intestinal Bacterial Overgrowth (SIBO)Small Intestinal Bacterial Overgrowth (SIBO)
Prevalencia: Estimated 6-15% in healthy population; up to 80% in IBS patients
Evidence-Ranked Ingredients
| Ingrediente | Calificación | Estudios | Dirección | |
|---|---|---|---|---|
| Partially Hydrolyzed Guar Gum (PHGG) | C | 2 | Positive | Ver → |
| Berberine | C | 2 | Positive | Ver → |
About
A condition characterized by excessive bacterial colonization of the small intestine, typically defined as >10^5 CFU/mL on jejunal aspirate or positive lactulose/glucose hydrogen breath test. Causes malabsorption due to bacterial consumption of nutrients and bile acid deconjugation.
Common Symptoms
Risk Factors
- IBS
- Gastric acid suppression (PPIs)
- Structural abnormalities
- Diabetes
- Hypothyroidism
- Prior abdominal surgery
- Chronic opioid use
Frequently Asked Questions
What supplements are studied for Small Intestinal Bacterial Overgrowth (SIBO)?
How is the evidence for Small Intestinal Bacterial Overgrowth (SIBO) supplements graded?
How many studies on Small Intestinal Bacterial Overgrowth (SIBO) supplements have been reviewed?
What are common symptoms of Small Intestinal Bacterial Overgrowth (SIBO)?
Related Conditions
Afecciones que comparten ingredientes estudiados
Aviso legal FDA: Estas declaraciones no han sido evaluadas por la Food and Drug Administration. Los productos y la información en este sitio web no están destinados a diagnosticar, tratar, curar ni prevenir ninguna enfermedad. Las calificaciones de evidencia presentadas se basan en nuestro análisis de investigación publicada revisada por pares y no constituyen consejo médico. Siempre consulte a su profesional de salud antes de comenzar cualquier régimen de suplementos.